| | | Single nucleotide variant (5 prime UTR variant +1 more) | Somatotroph adenoma +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Somatotroph adenoma +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Somatotroph adenoma +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Somatotroph adenoma +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | AIP, LOC130006206 (K69E +1 more) | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | AIP, LOC130006206 (I76V +1 more) | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | AIP, LOC130006206 (T20I +1 more) | Single nucleotide variant (missense variant) | Somatotroph adenoma +2 more | |
| | AIP, LOC130006206 (M80L +1 more) | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | |
| | AIP, LOC130006206 (Q28H +1 more) | Single nucleotide variant (missense variant) | Somatotroph adenoma +2 more | |